Citation tools
"Glycoprotein IIb/IIIa Receptor Antagonist CRL42796, in Combination with Aspirin and/or Enoxaparin, Prevents Coronary Artery Rethrombosis after Successful Thrombolytic Treatment by Recombinant Tissue Plasminogen Activator (rt-PA)1." Journal of Pharmacology and Experimental Therapeutics
(2003):
.
Web. 28 Mar. 2024.